ChiCTR2600117746 版本V1.1 版本创建时间2026/01/28 11:22:49 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600117746 

最近更新日期:

Date of Last Refreshed on:

2026-01-28 11:20:32 

注册时间:

Date of Registration:

2026-01-28 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

脑卒中患者与照顾者二元自我护理分类干预模式研究

Public title:

A study on the dyadic self-care subgroup classified intervention model between stroke survivor-caregiver dyads

注册题目简写:

English Acronym:

研究课题的正式科学名称:

脑卒中患者与照顾者二元自我护理交互模型构建及阶梯式干预模式研究

Scientific title:

A study on the dyadic self-care interaction model and step-by-step intervention model between stroke survivor-caregiver dyads

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

宋王涛 

研究负责人:

张振香 

Applicant:

Wangtao Song 

Study leader:

Zhenxiang Zhang 

申请注册联系人电话:

Applicant telephone:

+86 136 1384 7827

研究负责人电话:

Study leader's
telephone:

+86 133 0381 6666

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1229104697@qq.com

研究负责人电子邮件:

Study leader's E-mail:

zhangzx6666@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

河南省郑州市高新区科学大道101号

研究负责人通讯地址:

河南省郑州市高新区科学大道101号

Applicant address:

No.101, Kexuedadao Road, Zhengzhou City, Henan Province

Study leader's address:

No.101, Kexuedadao Road, Zhengzhou City, Henan Province

申请注册联系人邮政编码:

Applicant postcode:

450001

研究负责人邮政编码:

Study leader's postcode:

450001

申请人所在单位:

郑州大学护理与健康学院

Applicant's institution:

School of Nursing and Health,Zhengzhou University

研究负责人所在单位:

郑州大学护理与健康学院

Affiliation of the Leader:

School of Nursing and Health,Zhengzhou University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

ZZUIRB 2021-115

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

郑州大学生命科学伦理审查委员会

Name of the ethic committee:

Ethic Committee, Zhengzhou University

伦理委员会批准日期:

Date of approved by ethic committee:

2021-01-01 00:00:00

伦理委员会联系人:

郑州大学综合管理中心 426 房间

Contact Name of the ethic committee:

Room 426, Integrated Management Center, Zhengzhou University

伦理委员会联系地址:

河南省郑州市高新区科学大道101号

Contact Address of the ethic committee:

No.101, Kexuedadao Road, Zhengzhou City, Henan Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 67739539

伦理委员会联系人邮箱:

Contact email of the ethic committee:

xswyh@zzu.edu.cn

研究实施负责(组长)单位:

郑州大学护理与健康学院

Primary sponsor:

School of Nursing and Health,Zhengzhou University

研究实施负责(组长)单位地址:

河南省郑州市高新区科学大道101号

Primary sponsor's address:

No.101, Kexuedadao Road, Zhengzhou City, Henan Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

河南省

市(区县):

郑州市

Country:

China

Province:

Henan

City:

Zhengzhou

单位(医院):

郑州大学护理与健康学院

具体地址:

河南省郑州市高新区科学大道101号

Institution
hospital:

School of Nursing and Health,Zhengzhou University

Address:

No.101, Kexuedadao Road, Zhengzhou City, Henan Province

经费或物资来源:

国家自然科学基金项目(72174184)

Source(s) of funding:

National Natural Science Foundation of China (Grant number: 72174184)

研究疾病:

脑卒中  

Target disease:

Stroke

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

(1)构建脑卒中患者与照顾者二元自我护理分类干预方案。 (2)评价脑卒中患者与照顾者二元自我护理分类干预方案对改善脑卒中患者与照顾者二元自我护理行为、二者生活质量和照顾者负担的干预效果。  

Objectives of Study:

(1) Construct a binary self-care classification intervention program for stroke patients and their caregivers. (2) To evaluate the effect of the binary self-care classification intervention program for stroke patients and their caregivers on improving the binary self-care behavior of stroke patients and their caregivers, their quality of life and the burden of caregivers.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)脑卒中患者纳入标准:1)符合《中国各类主要脑血管病诊断要点2019》[80]脑卒中诊断标准,经颅脑CT或MRI确诊为脑卒中;2)年龄≥18岁;3)病情稳定,具有一定自理能力(改良版Barthel指数量表得分>60分[81]);4)认知正常(MMSE得分≥17分[82]),无明显沟通障碍(Token测试量表得分≥17分[83]);5)知情同意,自愿参与本研究;6)能够使用智能手机微信软件。 (2)脑卒中患者照顾者纳入标准:1)承担脑卒中患者主要照顾任务的非正式照顾者(如患者的配偶、子女等);2)年龄≥18岁;3)认知功能正常(MMSE得分≥17分),能正确清晰地回答问题(Token测试量表得分≥17分);4)承担患者主要照护责任,每日照顾患者时间≥4小时;5)知情同意,自愿参与;6)能够使用智能手机微信软件。

Inclusion criteria

Inclusion criteria of stroke patients: 1. patients met the diagnostic criteria of stroke in "The Diagnostic points of Major Cerebrovascular Diseases in China 2019" [80], and stroke was diagnosed by brain CT or MRI; 2. age >=18 years old; 3.stable condition with certain self-care ability (modified Barthel index score >60 points [81]); 4. normal cognition (MMSE score >=17 points [82]), no obvious communication disorder (Token test scale score >=17 points [83]); 5.Informed consent and voluntary participation in the study; 6. Able to use wechat software on smart phones. Inclusion criteria of caregivers of stroke patients: 1. Informal caregivers (such as spouses, children, etc.) who undertake the main care tasks of stroke patients;2. age >=18 years old; 3. normal cognitive function (MMSE score >=17 points) and able to answer questions correctly and clearly (Token test scale score >=17 points); 4. bear the main care responsibility for patients, and take care of patients for more than 4 hours per day; 5. informed consent and voluntary participation; ⑥ Able to use wechat software on smart phones.

排除标准:

(1)患者排除标准:1)伴有其他危重疾病者,如恶性肿瘤、心功能衰竭、肾功能衰竭、呼吸功能衰竭、严重外伤等其他危重病症者;2)正在参与其他研究者。 (2)照顾者排除标准:因个人原因不能配合调查。

Exclusion criteria:

Patinets' exclusion criteria: 1.Patients with other critical diseases, such as malignant tumors, heart failure, renal failure, respiratory failure, severe trauma and other critical diseases; 2. Participating in other investigators. Caregivers' exclusion criteria: unable to cooperate with the survey due to personal reasons.

研究实施时间:

Study execute time:

From 2024-12-01 00:00:00 To 2026-01-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-03-15 00:00:00 To 2025-09-01 00:00:00

干预措施:

Interventions:

组别:

干预组

样本量:

40

Group:

Intervention group

Sample size:

干预措施:

包含一个通用方案(所有参与者)和三个靶向方案(针对不同二元自我护理类型的二元组)。所有干预组的参与者都执行通用方案,不同类别二元组叠加对应的靶向干预方案。

干预措施代码:

Intervention:

Implementation Content: Contained a generic protocol (for all participants) and three targeted protocols (for dyadic groups with different dyadic self-care types). Participants in all intervention groups followed a common protocol, with the targeted intervention superimposed on each binary category.

Intervention code:

组别:

对照组

样本量:

40

Group:

Control group

Sample size:

干预措施:

对照组的参与者执行常规护理,即参与者接受研究团队成员的口头健康宣教,并为参与者提供医院统一为患者制定的教育手册。每两周电话随访患者一次。

干预措施代码:

Intervention:

Participants in the control group performed routine nursing, that is, participants received oral health education from the members of the research team, and provided participants with an education manual formulated by the hospital for patients. Follow-up patients by phone every two weeks.

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

河南省 

市(区县):

新乡市 

Country:

China

Province:

Henan

City:

Xinxiang

单位(医院):

新乡医学院第一附属医院 

单位级别:

三甲 

Institution
hospital:

The First Affiliated Hospital of Xinxiang Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

二元自我护理

指标类型:

主要指标

Outcome:

Dyadic self-care

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

患者和照顾者生活质量

指标类型:

次要指标

Outcome:

Stroke-caregiver dyads' quality of life

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

照顾者负担

指标类型:

次要指标

Outcome:

Caregiver Burden

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

对满足纳入及排除标准的患者进行计算机算计化法,将参与者分为对照组和干预组

Randomization Procedure (please state who generates the random number sequence and by what method):

The patients who met the inclusion and exclusion criteria were calculated by computer, and the participants were divided into control group and intervention group.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

本研究采用结局指标收集人员及统计分析人员盲法。

Blinding:

This study was blinded by outcome measure collectors and statistical analysts.

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

研究结束后6个月,经研究者同意后可邮箱获取;

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Six months after the study ends, it can be obtained via email with the researcher's consent.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集使用病历记录表,数据管理采用电子管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collection uses medical record form, and data management uses electronic management system.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2026-01-28 11:19:59